VisCardia, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Dec 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 6 to 27, 2026 · next Dec 6
- 1 fee due Jan 2, 2027The maintenance fee for Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation (US 10,335,592) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 1 fee due Feb 6, 2027The maintenance fee for Leads for implantable medical device that affects pressures within the intrathoracic cavity through diaphragmatic stimulation (US 10,369,361) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
- 1 fee due Jun 3, 2027The maintenance fee for Implantable medical devices, systems, and methods for selection of optimal diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity (US 10,493,271) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
- 1 fee due Jul 21, 2027The maintenance fee for Implantable medical devices and methods for real-time or near real-time adjustment of diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity (US 10,537,735) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (US 11,911,616) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
- 1 fee due Sep 12, 2027The maintenance fee for Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (US 11,925,803) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
- 1 fee due Oct 16, 2027The maintenance fee for Implantable medical systems, devices and methods for delivering asymptomatic diaphragmatic stimulation (US 11,957,914) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,994,655 | Mechanical, anatomical heart-pumping assist In force · From the USPTO record | In force | From the USPTO record | |
| US 9,694,185 | Hemodynamic performance enhancement through asymptomatic diaphragm stimulation In force · From the USPTO record | In force | From the USPTO record | |
| US 9,968,786 | Hemodynamic performance enhancement through asymptomatic diaphragm stimulation In force · From the USPTO record | In force | From the USPTO record | |
| US 10,315,035 | Hemodynamic Performance Enhancement Through Asymptomatic Diaphragm Stimulation In force · Low confidence | In force | Low confidence | |
| US 11,666,757 | Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation In force · From the USPTO record | In force | From the USPTO record | |
| US 12,144,993 | Hemodynamic performance enhancement through asymptomatic diaphragm stimulation In force · From the USPTO record | In force | From the USPTO record | |
| US 12,364,859 | Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation In force · From the USPTO record | In force | From the USPTO record | |
| US 11,020,596 | Hemodynamic performance enhancement through asymptomatic diaphragm stimulation In force · From the USPTO record | In force | From the USPTO record | |
| US 11,684,783 | Hemodynamic performance enhancement through asymptomatic diaphragm stimulation In force · From the USPTO record | In force | From the USPTO record | |
| US 9,498,625 | Hemodynamic performance enhancement through asymptomatic diaphragm stimulation In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.